ReleaseWire Connect

Electro-diagnostic (EDX) equipment is employed in studies to measure the electrical activity of nerves and muscles. The information revealed from the diagnosis helps physicians and clinicians in evaluating several conditions such as neuropathy, myopathy, plexopathy and neuromuscular junction disorder. The electro-diagnostic studies cover two specialized tests – electromyogram (EMG) and the nerve conduction study (NCS). The nerve conduction study (NCS) is the study of nerve function which involves applying small electrical impulses through electrodes placed on skin. While in the electromyogram (EMG), a small needle electrode is inserted into various muscles to reveal the status of the muscle's electrical activity.

Artificial implant is the procedure of replacement of a biological structure through a medical device. This medical device can be heart, dental fixtures or similar body parts enhancing or strengthening the damaged or existing biological structure. Medical implants are artificially manufactured or so called as manmade, contrast to the transplanting organs or tissue. Some of the implants include electronic devices too such as pacemaker while others are bioactive. The advent of the artificial implants has opened new horizons for the medical sector helping the patients with damaged biological structure to recover quickly with the embedded support. This new technique is getting popular as a result of the quick recovery catered by it.

A new research report has been recently published by Transparency Market Research and made available for sale on the company website. The research report, titled "Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", provides an in-depth analysis of the global medical imaging reagents market. According to the research study, in 2012, the global market for medical imaging reagents was worth US$10.3 bn and is projected to reach US$18.5 bn by the end of 2019, exhibiting a progressive 8.80% CAGR from 2013 to 2019.Some of the key factors boosting the medical imaging reagents market are the growing demand for diagnostic and functional imaging technologies and the rising incidence of cardiac disorders and cancers. The increasing opportunities of application of advanced medical reagents and rising concern for the safety of patients have propelled the medical imaging reagents market. However, the increased cost of development, supply shortages, lack of awareness, and rigid reimbursement structures are some of the factors that are expected to curb the growth of this market in the near future.

In response to the expanding healthcare industry, the amount of medical waste generated around the world has also substantially increased, thus making global medical waste management market imperative for any society. The report, titled "Medical Waste Management Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," published by Transparency Market Research aims to provide a granular analysis of the evolution of the market and the key factors impacting its growth trajectory. Medical waste refers to the waste generated in healthcare institutions such as hospitals, physician's offices, clinics, dental hospitals, veterinary clinics or hospitals, blood banks, and medical research institutes, laboratories, or facilities. This waste may include solid waste that is generated during diagnosis, treatment, or immunization of human beings or animals, during the testing or production of biologics or any research pertaining thereto. The definition of medical waste is therefore not limited to blood soaked bandages, discarded surgical instruments, or culture dishes and other glassware.

According to estimations of the TMR report, the demand in the global plasma protease c1-inhibitor treatment market will expand at a strong 20.0% CAGR for the forecast period of 2017 to 2025, for the market to be evaluated at US$7.9 bn by 2025-end considerably up from its evaluated worth of US$1.5 bn in 2016. Key vendors in the plasma protease c1-inhibitor treatment market are engaged in expanding their product portfolio and expand their distribution networks in order to penetrate global markets. This has mandated vendors to meet the regulatory standards set by governing bodies at national and international level.

As per estimates presented in a report by TMR, the demand global antithrombin market will rise at a CAGR of 5.2% for the forecast period of 2017 to 2025. The market for antithrombin is predicted to attract a revenue of US$704.5 mn by the end of 2025 from US$448.2 mn in 2016.

According to the research report, the worldwide hemostasis diagnostics market is projected to attract a revenue of US$3,979.5 mn by 2025 from US$1,960.0 mn in 2016 at a CAGR of 8.3% between 2017 and 2025. Hospitals end-user segment is likely to exhibit most promising demand over other end-users in the hemostasis diagnostics market over the forecast period. North America holds dominance in the global hemostasis market, and the trend is anticipated to continue over the forecast period.

The global endoscopy equipment market is likely to exhibit a strong 4% CAGR in the 2017-2022 forecast period, rising from a likely 2017-end valuation of US$27.5 bn to US$33.5 bn by the end of 2022. Analysts at Transparency Market Research have attributed the growth of the endoscopy equipment market to a number of factors.

As per a study by Transparency Market Research, the global high-flow nasal cannula market will expand at a steady pace in the upcoming years. The report estimates that the market was worth US$3.42 bn 2016. Rising at a solid CAGR of 11.8% during the period between 2017 and 2025, the market will likely attain a value of US$9.08 bn by 2025, it predicts.

The TMR report has foreseen the Asia Pacific single-use bioprocessing systems market to earn a valuation of US$1.4 bn by the end of 2024 from US$0.4 bn in 2015 at a decent CAGR of 12.50% for the forecast period 2016–2024. The pharmaceutical industry could top the market on the basis of end use, considering its 34.5% share in 2015 and several factors fueling growth. With a 33.0% share achieved in the same year, China has been prophesied to be another opportunity to cash in on until the concluding forecast year.